BioAdvance News Portfolio News Venatorx Pharmaceuticals

VenatoRx Pharmaceuticals Expands Development Team as It Advances Its Antibacterial and Antiviral Portfolio

By WebmasterAugust 21, 2019November 1st, 2024No Comments

VenatoRx Pharmaceuticals Expands Development Team as It Advances Its Antibacterial and Antiviral Portfolio
Key Hires in Quality Assurance, Medical Sciences and Regulatory Affairs

See more here

Previous PostBainbridge Health Partners with Tabula Rasa HealthCare's subsidiary DoseMe To Expand Medication Management Capabilities to Health Systems(s)
Next PostGroup K Diagnostics and Health Network Laboratories Announce the Commencement of a Clinical Trial

VenatoRx Pharmaceuticals Expands Development Team as It Advances Its Antibacterial and Antiviral Portfolio

SEARCH

TOPICS

ARCHIVES

RECENT POSTS

Previous PostBainbridge Health Partners with Tabula Rasa HealthCare's subsidiary DoseMe To Expand Medication Management Capabilities to Health Systems(s)

Next PostGroup K Diagnostics and Health Network Laboratories Announce the Commencement of a Clinical Trial